Hennion & Walsh Asset Management, Inc. Applied Therapeutics Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.15 Billion
- Q1 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 301,303 shares of APLT stock, worth $102,443. This represents 0.01% of its overall portfolio holdings.
Number of Shares
301,303
Previous 313,355
3.85%
Holding current value
$102,443
Previous $266,000
41.35%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding APLT
# of Institutions
94Shares Held
103MCall Options Held
176KPut Options Held
165K-
Vestal Point Capital, LP New York, NY11.5MShares$3.91 Million0.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$3.84 Million6.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$3.53 Million0.0% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$2.65 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$2.23 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $16.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...